These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vestibular and hearing manifestations of phenytoin toxicity: a retrospective series. De Diego JI, Prim MP, Marcos S, De Sarria MJ, Arpa J, Gavilan J. Ear Nose Throat J; 2001 Jun; 80(6):404, 407-9. PubMed ID: 11433844 [Abstract] [Full Text] [Related]
7. Therapeutic drug monitoring of phenytoin in critically ill patients. von Winckelmann SL, Spriet I, Willems L. Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999 [Abstract] [Full Text] [Related]
8. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. Yegnanarayan R, Mahesh SD, Sangle S. Chronobiol Int; 2006 Nov; 23(5):1035-46. PubMed ID: 17050216 [Abstract] [Full Text] [Related]
9. Management of the difficult patient with complex partial seizures. Booker HE. Adv Neurol; 1975 Nov; 11():369-82. PubMed ID: 1217570 [Abstract] [Full Text] [Related]
10. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study]. Hernández R, Fernández Mde L, Miranda G, Suástegui R. Rev Invest Clin; 2005 Nov; 57(4):522-31. PubMed ID: 16315636 [Abstract] [Full Text] [Related]
11. Phenytoin toxicity presenting as acute meningo-encephalitis in children. Gupta V, Yadav TP, Yadav A. Neurol India; 2011 Nov; 59(1):66-7. PubMed ID: 21339662 [Abstract] [Full Text] [Related]
12. Risk of seizures from concomitant use of ciprofloxacin and phenytoin in patients with epilepsy. Springuel P. CMAJ; 1998 Jan 13; 158(1):104-5, 108-9. PubMed ID: 9475922 [No Abstract] [Full Text] [Related]